New agents for prevention of ultraviolet-induced nonmelanoma skin cancer
Related Experiment Video
Updated: Jun 2, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
William L Camp1, Jennifer W Turnham, Mohammad Athar
1Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Abstract:
With the incidence of nonmelanoma skin cancer on the rise, current prevention methods, such as the use of sunscreens, have yet to prove adequate to reverse this trend. There has been considerable interest in identifying compounds that will inhibit or reverse the biochemical changes required for skin cancers to develop, either by pharmacologic intervention or by dietary manipulation. By targeting different pathways identified as important in the pathogenesis of nonmelanoma skin cancers, a combination approach with multiple agents or the addition of chemopreventative agents to topical sunscreens may offer the potential for novel and synergistic therapies in treating nonmelanoma skin cancer.
Insights
Nonmelanoma skin cancer is increasing, and current sunscreens are insufficient. New research explores compounds and combination therapies to prevent and treat skin cancer by targeting key biochemical pathways.
Area of Science:
- Oncology
- Dermatology
- Biochemistry
Background:
- Rising incidence of nonmelanoma skin cancer (NMSC) indicates limitations of current preventive measures like sunscreens.
- There is a growing need for novel strategies to inhibit or reverse the biochemical processes driving NMSC development.
- Pharmacologic interventions and dietary modifications are being explored for NMSC prevention and treatment.
Purpose of the Study:
- To investigate novel chemopreventive agents and combination therapies for nonmelanoma skin cancer.
- To identify compounds that can inhibit or reverse critical biochemical changes in NMSC pathogenesis.
- To explore the potential of targeting specific molecular pathways involved in NMSC.
Main Methods:
- Review of current literature on NMSC pathogenesis and prevention.
- Identification of key biochemical pathways implicated in NMSC development.
- Exploration of pharmacologic and dietary approaches for chemoprevention.
- Consideration of combination therapies and adjuncts to topical sunscreens.
Main Results:
- Current prevention methods, including sunscreens, are inadequate against rising NMSC rates.
- Compounds targeting specific pathways show promise for inhibiting NMSC development.
- Combination approaches may offer synergistic therapeutic potential.
Conclusions:
- Novel chemopreventive strategies are needed to combat increasing nonmelanoma skin cancer incidence.
- Targeting specific biochemical pathways offers a promising avenue for NMSC intervention.
- Combination therapies, potentially including agents added to sunscreens, may provide enhanced NMSC treatment options.
More Related Videos
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cancer Prevention
Some...
Cancer Prevention
Some...
Acne Infection
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
